Navigation Links
Physicians Choice Laboratory Services (PCLS) is Now Offering Beckman Coulter Diagnostics’ Prostate Health Index (phi).
Date:5/8/2015

(PRWEB) May 08, 2015

Today, PCLS is pleased to announce that they have added Beckman Coulter’s Prostate Health Index (phi) to the urologic health testing menu, providing access to physicians across the United States.

According to the American Cancer Society, about 220,800 new cases of prostate cancer will be diagnosed this year. Prostate cancer occurs mainly in men older than 50 years of age and is the second leading cause of cancer death among American men, behind only lung cancer. Prostate cancer is a serious disease, but most men diagnosed with prostate cancer do not die from the disease. Screening and early detection are important in order for men to catch prostate cancer early, but choosing the right screening method can be difficult. The PSA (prostate-specific antigen) test is currently the most widely used screening test for prostate cancer, but because of its limited specificity, many patients undergo prostate biopsy unnecessarily.
The Prostate Health Index (phi) is:

  •     A simple blood test that is three times more specific for the detection of prostate cancer than PSA alone1
  •     The only multi-analyte prostate cancer blood test with FDA approval2
  •     The only multi-analyte blood test recommended in the National Comprehensive Cancer Network Guidelines (NCCN) for prostate cancer early detection.
The phi test helps physicians distinguish prostate cancer by combining three PSA markers (PSA, freePSA and p2PSA) as part of a sophisticated algorithm to accurately determine the probability of cancer in patients with elevated PSA levels and substantially reduce the number of negative biopsies. The increase in accuracy of the phi test over PSA addresses physician’s concerns regarding the decision to biopsy. Results from a multi-center clinical study found a 31 percent reduction in unnecessary biopsies due to false-positives as a result of using the phi test. 3
“PCLS is excited to be working with an industry leader like Beckman Coulter to expand our urologic health offerings. The phi test is a step in the right direction toward better prostate cancer management and PCLS is pleased to be one of only two laboratories offering the test to physicians throughout the U.S,” said Joe Wiegel, PCLS President and CEO. “According to a recent study published in the Journal of Urology, phi is 3 times more specific than PSA and offers doctors and patients a better way to determine if a prostate biopsy is appropriate. Currently, 75 percent of prostate biopsies performed are negative for cancer. Phi will help reduce the number of men that undergo a prostate biopsy unnecessarily, thereby reducing the number of complications associated with the biopsy procedure and treatment of non-life threatening disease.”

About PCLS
PCLS is an emerging esoteric laboratory that goes beyond testing to provide innovative solutions to healthcare problems. PCLS has a unique mix of services that are designed to inform physicians about their patient’s health status relative to several difficult to manage disease states including narcotic misuse and abuse, neonatal abstinence syndrome, titrating psychiatric drugs for debilitating mental disorders, recurrent/resistant bacterial infections, heart disease, gastrointestinal/urogenital disorders and cancers. The company has broadly invested in offering high value diagnostics that enable personalized and precision medicine to better manage these complicated disease states with the goal of improving health outcomes.

References:
1.    Catalona WJ, Partin AW, Sanda MG, et al. A multicenter study of [-2]pro-prostate-specific antigen combined with prostate-specific antigen and free prostate-specific antigen for prostate cancer detection in the 2.0 to 10.0 ng/mL prostate-specific antigen range. J Urology 2011 May;185:1650-55.
2.    phi is a combination of three Beckman Coulter assays: Access Hybritech PSA, Access Hybritech free PSA, and Access Hybritech p2PSA.
3.    Beckman Coulter U.S. Prostate Cancer Pivotal Study Report

Read the full story at http://www.prweb.com/releases/2015/05/prweb12710265.htm.


'/>"/>
Source: PRWeb
Copyright©2015 Vocus, Inc.
All rights reserved

Related medicine news :

1. Physicians’ Education Resource®, LLC (PER®), to Present “Best-in-Class Outcomes” Poster for Oncology Continuing Medical Education Reminiscent of Medical School
2. Current, Evidence-Based Knowledge for Physicians: UpToDate supports quick and accurate decision support for diagnosis and treatment
3. New UC Davis Program Targets Next Generation of Physicians to Advance Latino Health
4. Allied Anesthesia Physicians Promote Gentle C-sections
5. Providence Fertility Center Physicians Will Be Featured on WPRI 12’s Rhode Show during National Infertility Awareness Week April 20-24
6. Healthcare Staffing Agency, Aureus Medical Group, to Exhibit at the American College of Physicians Internal Medicine Meeting
7. Winscribe Quick Speech Recognition Enhances EMR Usability and Provides Speech-Enabled Documentation for Physicians
8. Brightbox Safe & Secure Mobile Device Recharging Boosts Healthcare Industry Satisfaction While Maintaining Privacy at Healthcare Marketing & Physicians Strategies Summit
9. The Physicians at Plastic Surgery Center Each Have Something to Celebrate This March
10. Florida Hospital Welcome Dr. Oz to Tampa and Invites the Community to Attend Educational Seminars Hosted by Florida Hospital Physicians
11. Multispecialty Office Brings Sleep Experts and Physicians to Doctors on Liens
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/23/2017)... ... June 23, 2017 , ... MD Now Urgent Care ... MD Now’s 28th facility overall and marks the urgent care center's eighth location in ... North of The Falls shopping mall. The new clinic offers a wide array of ...
(Date:6/23/2017)... ... ... American Farmer, will feature Chr. Hansen, Inc (CHR Hansen) in an upcoming episode ... Farmer airs Tuesdays at 8:30aET on RFD-TV. Check your local listings for more info. ... 1874 after a groundbreaking discovery of how to industrialize enzymes. Rooted in science and ...
(Date:6/23/2017)... Chicago, IL (PRWEB) , ... June 23, 2017 ... ... insurance management assistance and financial planning services to communities in the greater Chicago ... Children’s Association to offer assistance to underprivileged youth in Chicago. , Founded in ...
(Date:6/23/2017)... ... June 23, 2017 , ... Moore Insurance, ... area with access to asset protection and financial planning services, is teaming up ... improving the lives of children with cancer and other chronic diseases. , The ...
(Date:6/22/2017)... ... June 22, 2017 , ... ... is pleased to welcome Whipple & Company as its newest Partner Firm. Headquartered ... of balancing their clients’ risk while tailoring optimized benefit packages that strengthen the ...
Breaking Medicine News(10 mins):
(Date:6/2/2017)... , June 2, 2017  NxStage Medical, Inc. (Nasdaq:  NXTM), a ... today announced new findings demonstrating positive biochemical outcomes related ... System One™. The data will be presented at the ... Madrid, Spain . The ... Home Dialysis Network in Europe ...
(Date:5/29/2017)... Israel, May 29, 2017  Cellect Biotechnology Ltd. (NASDAQ: ... technology which enables the functional selection of stem cells, ... for the first quarter ended March 31 st , ... our accomplishments in the first quarter of 2017," said ... quarter, we announced the treatment of the first blood ...
(Date:5/22/2017)... VALLEY COTTAGE, N.Y. , May 22, 2017 ... natural antiviral treatment Gene-Eden-VIR/Novirin, announces the launch of ... in plain English, the results of a clinical ... after one year treatment with Gene-Eden-VIR/Novirin in individuals ... is important to note that there are no ...
Breaking Medicine Technology: